The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

Myelodysplastic syndromes (MDS) are hematopoietic stem cell malignancies associated with an erythroid maturation defect, resulting in anemia. Treatments for MDS include erythropoiesis-stimulating agents (ESAs). The identification of prognostic markers is important to help predict response and improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sophie, Kelaidi, Charikleia, Meunier, Mathieu, Casadevall, Nicole, Gerds, Aaron T., Platzbecker, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944671/
https://www.ncbi.nlm.nih.gov/pubmed/31650290
http://dx.doi.org/10.1007/s00277-019-03799-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944671/
https://www.ncbi.nlm.nih.gov/pubmed/31650290
http://dx.doi.org/10.1007/s00277-019-03799-4

Ejemplares similares